Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial-Reference-Cited by-同舟云学术

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

Published:2017-01 Issue:10066 Volume:389 Page:266-275
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Vermeire Séverine,Schreiber Stefan,Petryka Robert,Kuehbacher Tanja,Hebuterne Xavier,Roblin Xavier,Klopocka Maria,Goldis Adrian,Wisniewska-Jarosinska Maria,Baranovsky Andrey,Sike Robert,Stoyanova Kremena,Tasset Chantal,Van der Aa Annegret,Harrison Pille

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Crohn's disease;Baumgart;Lancet,2012

2. A review of Crohn's disease;Hendy;Eur Med J,2013

3. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015

4. The natural history of adult Crohn's disease in population-based cohorts;Peyrin-Biroulet;Am J Gastroenterol,2010

5. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases;Schwartz;Nat Rev Rheumatol,2016

Cited by 365 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease;Cytokine & Growth Factor Reviews;2024-10

2. Risk of nonmelanoma skin cancer in patients taking Janus kinase inhibitors for inflammatory bowel disease: A systematic review and meta-analysis;Dermatologica Sinica;2024-09-04

3. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

4. Epithelial barrier dysfunction and microbial dysbiosis: exploring the pathogenesis and therapeutic strategies for Crohn’s disease;Tissue Barriers;2024-08-26

5. Terápiás kihívások nehezen kezelhető, penetráló Crohn-betegségben – multidiszciplináris megoldás;Orvosi Hetilap;2024-08-11